• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

工程化纳米药物生物界面以克服精准药物递送的生物屏障。

Engineering nano-drug biointerface to overcome biological barriers toward precision drug delivery.

机构信息

Department of Burn and Plastic Surgery, Shenzhen Institute of Translational Medicine, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital, Shenzhen, 518035, China.

Department of Biomedical Engineering, School of Medicine, Shenzhen University, Shenzhen, 518060, China.

出版信息

J Nanobiotechnology. 2022 Aug 31;20(1):395. doi: 10.1186/s12951-022-01605-4.

DOI:10.1186/s12951-022-01605-4
PMID:36045386
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9428887/
Abstract

The rapid advancement of nanomedicine and nanoparticle (NP) materials presents novel solutions potentially capable of revolutionizing health care by improving efficacy, bioavailability, drug targeting, and safety. NPs are intriguing when considering medical applications because of their essential and unique qualities, including a significantly higher surface to mass ratio, quantum properties, and the potential to adsorb and transport drugs and other compounds. However, NPs must overcome or navigate several biological barriers of the human body to successfully deliver drugs at precise locations. Engineering the drug carrier biointerface can help overcome the main biological barriers and optimize the drug delivery in a more personalized manner. This review discusses the significant heterogeneous biological delivery barriers and how biointerface engineering can promote drug carriers to prevail over hurdles and navigate in a more personalized manner, thus ushering in the era of Precision Medicine. We also summarize the nanomedicines' current advantages and disadvantages in drug administration, from natural/synthetic sources to clinical applications. Additionally, we explore the innovative NP designs used in both non-personalized and customized applications as well as how they can attain a precise therapeutic strategy.

摘要

纳米医学和纳米粒子(NP)材料的快速发展提供了新的解决方案,有可能通过提高疗效、生物利用度、药物靶向和安全性来彻底改变医疗保健。由于其独特的性质,包括更高的表面积与质量比、量子特性以及吸附和输送药物和其他化合物的潜力,NP 在医学应用中具有吸引力。然而,NP 必须克服或解决人体的几个生物屏障,才能成功地将药物递送到精确的位置。药物载体生物界面的工程设计有助于克服主要的生物屏障,并以更个性化的方式优化药物输送。本文讨论了显著的异质生物输送障碍,以及生物界面工程如何帮助药物载体克服障碍并以更个性化的方式进行导航,从而开启精准医学的时代。我们还总结了纳米医学在药物管理方面的当前优势和劣势,包括从天然/合成来源到临床应用。此外,我们还探讨了非个性化和定制应用中使用的创新 NP 设计,以及它们如何实现精确的治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e237/9429769/e724183b3076/12951_2022_1605_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e237/9429769/49c2dec67403/12951_2022_1605_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e237/9429769/7b8d7fba2eaf/12951_2022_1605_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e237/9429769/165f381b6073/12951_2022_1605_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e237/9429769/e604541706cf/12951_2022_1605_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e237/9429769/8ed5cc09241e/12951_2022_1605_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e237/9429769/2c974ed6d515/12951_2022_1605_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e237/9429769/e724183b3076/12951_2022_1605_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e237/9429769/49c2dec67403/12951_2022_1605_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e237/9429769/7b8d7fba2eaf/12951_2022_1605_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e237/9429769/165f381b6073/12951_2022_1605_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e237/9429769/e604541706cf/12951_2022_1605_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e237/9429769/8ed5cc09241e/12951_2022_1605_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e237/9429769/2c974ed6d515/12951_2022_1605_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e237/9429769/e724183b3076/12951_2022_1605_Fig7_HTML.jpg

相似文献

1
Engineering nano-drug biointerface to overcome biological barriers toward precision drug delivery.工程化纳米药物生物界面以克服精准药物递送的生物屏障。
J Nanobiotechnology. 2022 Aug 31;20(1):395. doi: 10.1186/s12951-022-01605-4.
2
Engineering precision nanoparticles for drug delivery.工程化精准纳米颗粒用于药物递送。
Nat Rev Drug Discov. 2021 Feb;20(2):101-124. doi: 10.1038/s41573-020-0090-8. Epub 2020 Dec 4.
3
Engineering the drug carrier biointerface to overcome biological barriers to drug delivery.工程化药物载体生物界面以克服药物传递的生物学屏障。
Adv Drug Deliv Rev. 2020 Dec;167:89-108. doi: 10.1016/j.addr.2020.06.007. Epub 2020 Jun 11.
4
A review of DNA nanoparticles-encapsulated drug/gene/protein for advanced controlled drug release: Current status and future perspective over emerging therapy approaches.DNA 纳米颗粒包裹药物/基因/蛋白质用于先进的控制药物释放的综述:新兴治疗方法的现状和未来展望。
Int J Biol Macromol. 2024 May;268(Pt 1):131694. doi: 10.1016/j.ijbiomac.2024.131694. Epub 2024 Apr 18.
5
Tumor-Acidity-Cleavable Maleic Acid Amide (TACMAA): A Powerful Tool for Designing Smart Nanoparticles To Overcome Delivery Barriers in Cancer Nanomedicine.肿瘤酸度裂解马来酸酰胺(TACMAA):设计智能纳米粒子克服癌症纳米医学中输送障碍的强大工具。
Acc Chem Res. 2018 Nov 20;51(11):2848-2856. doi: 10.1021/acs.accounts.8b00195. Epub 2018 Oct 15.
6
Engineering a Nano/Biointerface for Cell and Organ-Selective Drug Delivery.工程化纳米/生物界面实现细胞和器官选择性药物递送。
Langmuir. 2022 Aug 2;38(30):9092-9098. doi: 10.1021/acs.langmuir.2c01609. Epub 2022 Jul 19.
7
Engineering nanosystems to overcome barriers to cancer diagnosis and treatment.工程纳米系统克服癌症诊断和治疗的障碍。
Adv Drug Deliv Rev. 2022 Oct;189:114482. doi: 10.1016/j.addr.2022.114482. Epub 2022 Aug 6.
8
Targeted nanomedicine for cancer therapeutics: Towards precision medicine overcoming drug resistance.癌症治疗的靶向纳米医学:迈向克服耐药性的精准医学。
Drug Resist Updat. 2017 Mar;31:15-30. doi: 10.1016/j.drup.2017.05.002. Epub 2017 May 21.
9
Personalized Nanoparticles for Cancer Therapy: A Call for Greater Precision.用于癌症治疗的个性化纳米颗粒:呼吁更高的精准度。
Anticancer Agents Med Chem. 2017;17(8):1033-1039. doi: 10.2174/1871520617666170102150730.
10
Unlocking the Mitochondria for Nanomedicine-based Treatments: Overcoming Biological Barriers, Improving Designs, and Selecting Verification Techniques.为基于纳米医学的治疗方法解锁线粒体:克服生物学障碍、改进设计和选择验证技术。
Adv Drug Deliv Rev. 2024 Apr;207:115195. doi: 10.1016/j.addr.2024.115195. Epub 2024 Feb 5.

引用本文的文献

1
Enhancing the therapeutical potential of metalloantibiotics using nano-based delivery systems.利用基于纳米的递送系统提高金属抗生素的治疗潜力。
Beilstein J Nanotechnol. 2025 Aug 15;16:1350-1366. doi: 10.3762/bjnano.16.98. eCollection 2025.
2
The Nanocarrier Landscape─Evaluating Key Drug Delivery Vehicles and Their Capabilities: A Translational Perspective.纳米载体全景——评估关键药物递送载体及其性能:转化视角
ACS Appl Mater Interfaces. 2025 Jul 2;17(26):37383-37403. doi: 10.1021/acsami.5c07366. Epub 2025 Jun 17.
3
Optimizing the Size of Zr-Based Metal-Organic Frameworks for Enhanced Anticancer Efficacy.

本文引用的文献

1
protein corona on nanoparticles: does the control of all material parameters orient the biological behavior?纳米颗粒上的蛋白质冠层:所有材料参数的控制是否能引导生物学行为?
Nanoscale Adv. 2021 Jan 13;3(5):1209-1229. doi: 10.1039/d0na00863j. eCollection 2021 Mar 9.
2
Exploring near-infrared absorbing nanocarriers to overcome cancer drug resistance.探索近红外吸收纳米载体以克服癌症耐药性。
Cancer Drug Resist. 2020 Jul 2;3(3):302-333. doi: 10.20517/cdr.2020.20. eCollection 2020.
3
New advances in exosome-based targeted drug delivery systems.
优化锆基金属有机框架的尺寸以增强抗癌效果。
Nanomaterials (Basel). 2025 May 29;15(11):826. doi: 10.3390/nano15110826.
4
Nanomedicine in Cancer Therapeutics: Current Perspectives from Bench to Bedside.癌症治疗中的纳米医学:从实验室到临床的当前视角
Mol Cancer. 2025 Jun 9;24(1):169. doi: 10.1186/s12943-025-02368-w.
5
Design and evaluation of carnosic acid-loaded thermosensitive lipidic nanogels for nasal delivery: ex vivo permeation, nasal ciliotoxicity, and antioxidant assessment.用于鼻腔给药的富含鼠尾草酸的热敏脂质纳米凝胶的设计与评价:体外渗透、鼻纤毛毒性及抗氧化评估
3 Biotech. 2025 Jun;15(6):193. doi: 10.1007/s13205-025-04367-6. Epub 2025 May 28.
6
Nanocarrier-based targeted drug delivery for Alzheimer's disease: addressing neuroinflammation and enhancing clinical translation.基于纳米载体的阿尔茨海默病靶向药物递送:应对神经炎症并加强临床转化
Front Pharmacol. 2025 May 14;16:1591438. doi: 10.3389/fphar.2025.1591438. eCollection 2025.
7
Immune Modulation with Oral DNA/RNA Nanoparticles.口服DNA/RNA纳米颗粒的免疫调节
Pharmaceutics. 2025 May 4;17(5):609. doi: 10.3390/pharmaceutics17050609.
8
Alleviation of Neurological Disorders by Targeting Neurodegenerative-Associated Enzymes: Natural and Synthetic Molecules.通过靶向神经退行性相关酶缓解神经疾病:天然和合成分子
Int J Mol Sci. 2025 May 14;26(10):4707. doi: 10.3390/ijms26104707.
9
High-Efficiency Drug Loading in Lipid Vesicles by MEMS-Driven Gigahertz Acoustic Streaming.通过微机电系统驱动的千兆赫兹声流在脂质囊泡中实现高效药物负载。
Micromachines (Basel). 2025 May 7;16(5):562. doi: 10.3390/mi16050562.
10
Precision-Guided Stealth Missiles in Biomedicine: Biological Carrier-Mediated Nanomedicine Hitchhiking Strategy.生物医学中的精确制导隐形导弹:生物载体介导的纳米药物搭便车策略。
Adv Sci (Weinh). 2025 Jun;12(21):e2504672. doi: 10.1002/advs.202504672. Epub 2025 May 8.
基于外泌体的靶向药物传递系统的新进展。
Crit Rev Oncol Hematol. 2022 Apr;172:103628. doi: 10.1016/j.critrevonc.2022.103628. Epub 2022 Feb 18.
4
Lipid-Coated CaCO Nanoparticles as a Versatile pH-Responsive Drug Delivery Platform to Enable Combined Chemotherapy of Breast Cancer.脂质包覆的碳酸钙纳米颗粒作为一种多功能pH响应型药物递送平台用于实现乳腺癌的联合化疗。
ACS Appl Bio Mater. 2022 Mar 21;5(3):1194-1201. doi: 10.1021/acsabm.1c01234. Epub 2022 Feb 18.
5
Bugs as drugs: neglected but a promising future therapeutic strategy in cancer.以菌治癌:被忽视但极具前景的癌症治疗策略
Future Oncol. 2022 Apr;18(13):1609-1626. doi: 10.2217/fon-2021-1137. Epub 2022 Feb 9.
6
Green approaches for the synthesis of metal and metal oxide nanoparticles using microbial and plant extracts.使用微生物和植物提取物合成金属和金属氧化物纳米粒子的绿色方法。
Nanoscale. 2022 Feb 17;14(7):2534-2571. doi: 10.1039/d1nr08144f.
7
The ancillary effects of nanoparticles and their implications for nanomedicine.纳米粒子的辅助效应及其对纳米医学的影响。
Nat Nanotechnol. 2021 Nov;16(11):1180-1194. doi: 10.1038/s41565-021-01017-9. Epub 2021 Nov 10.
8
Carrier-free nanodrugs with efficient drug delivery and release for cancer therapy: From intrinsic physicochemical properties to external modification.用于癌症治疗的具有高效药物递送和释放功能的无载体纳米药物:从固有物理化学性质到外部修饰
Bioact Mater. 2021 Jul 6;8:220-240. doi: 10.1016/j.bioactmat.2021.06.035. eCollection 2022 Feb.
9
Endocytosis of abiotic nanomaterials and nanobiovectors: Inhibition of membrane trafficking.非生物纳米材料和纳米生物载体的内吞作用:膜运输的抑制
Nano Today. 2021 Oct;40:101279. doi: 10.1016/j.nantod.2021.101279. Epub 2021 Sep 8.
10
Novel nanomedicines to overcome cancer multidrug resistance.新型纳米药物克服癌症多药耐药性。
Drug Resist Updat. 2021 Sep;58:100777. doi: 10.1016/j.drup.2021.100777. Epub 2021 Aug 4.